10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
13.08
-0.37 (-2.75%)
At close: Aug 1, 2025, 4:00 PM
12.90
-0.18 (-1.38%)
After-hours: Aug 1, 2025, 7:12 PM EDT

Company Description

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the Americas, Europe, the Middle East, Africa, China, and the Asia Pacific.

It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; Visium platform includes Spatial Gene Expression, HD Spatial Gene Expression, and Spatial Gene and Protein Expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section.

It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014.

10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

10x Genomics, Inc.
10x Genomics logo
CountryUnited States
Founded2012
IPO DateSep 12, 2019
IndustryHealth Information Services
SectorHealthcare
Employees1,306
CEOSerge Saxonov

Contact Details

Address:
6230 Stoneridge Mall Road
Pleasanton, California 94588-3260
United States
Phone925 401 7300
Website10xgenomics.com

Stock Details

Ticker SymbolTXG
ExchangeNASDAQ
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$39.00
CIK Code0001770787
CUSIP Number88025U109
ISIN NumberUS88025U1097
Employer ID45-5614458
SIC Code3826

Key Executives

NamePosition
Dr. Serge Saxonov Ph.D.Co-Founder, Chief Executive Officer and Director
Dr. Benjamin J. Hindson Ph.D.Co-Founder, President, Chief Scientific Officer and Director
Adam S. TaichChief Financial Officer, Treasurer, Principal Financial Officer and Principal Accounting Officer
Eric S. Whitaker Esq.Chief Legal Officer
Jim GoodrichChief of Global Operations
Michael Schnall-LevinFounding Scientist and Chief Technology Officer
Cassie CorneauManager of Investor Relations and Strategic Finance
Mennah MoustafaChief Commercial Officer
Jens DurruthyAssociate Director of Product Management

Latest SEC Filings

DateTypeTitle
Jul 31, 2025SCHEDULE 13GFiling
Jul 16, 2025SCHEDULE 13G/AFiling
Jun 5, 20258-KCurrent Report
May 22, 2025144Filing
May 22, 2025144Filing
May 22, 2025144Filing
May 14, 20258-KCurrent Report
May 14, 2025SCHEDULE 13G/AFiling
May 12, 2025SCHEDULE 13G/AFiling
May 9, 202510-QQuarterly Report